Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
about
Tertiary Lymphoid Organs in Central Nervous System AutoimmunityOutcome Measures in Clinical Trials for Multiple Sclerosis.Primary Progressive Multiple Sclerosis: Putting Together the PuzzleClinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.Unprovoked seizures in multiple sclerosis: Why are they rare?Lesion symptom map of cognitive-postural interference in multiple sclerosis.Key clinical benefits of neuroimaging at 7T.MRI and multiple sclerosis--the evolving role of MRI in the diagnosis and management of MS: the radiologist's perspective.Is There a Relationship Between Multiple Sclerosis and Epilepsy? If So What Does It Tell Us About Epileptogenesis?Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.Disruption of neurite morphology parallels MS progressionClonal Glial Response in a Multiple Sclerosis Mouse ModelA comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression
P2860
Q28071379-5E45AD2C-CA44-44EE-927E-651BF12BE4ABQ31160866-89E713E6-BE16-4A7E-BB9B-D6780B1A1474Q33365606-357F3A02-6B53-4857-8560-47C5AA030CEBQ35997017-B3C747A2-280B-4802-883E-95C7ECCE51BCQ36455070-0AF29683-59C4-4F17-BED4-35AF3986A976Q37004557-331A1872-07B6-474A-AFB1-A16B749261F9Q39449276-C63E3AE7-5DC6-48F9-8904-C60F40CE94E3Q48247605-84F2FC2C-BAF9-44A6-9A52-EB76240C3028Q48428333-901DED50-960D-427C-A05C-488B771CD7B6Q49606221-020571CF-2847-4C76-B6CB-58F5B6740E21Q55128191-64C6117B-B083-4FE9-ACEA-AE40CD11658BQ55502196-C938ABCC-18C4-4326-BBDC-E22998D48F97Q57821321-22773D1D-EB64-4072-B39F-DBE4F4741521Q58572084-226E0866-908A-4E79-918C-422B7EABC813Q58763252-F25E22A2-7F6B-4A12-A58F-C857561A13CD
P2860
Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
@ast
Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
@en
type
label
Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
@ast
Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
@en
prefLabel
Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
@ast
Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
@en
P2093
P1433
P1476
Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
@en
P2093
Bernard M J Uitdehaag
Henry C Weinstein
Jeroen J G Geurts
P304
P356
10.1016/J.NEUROSCIENCE.2015.07.006
P407
P577
2015-07-08T00:00:00Z